An Ottawa public servant fights her health plan's denial of a weight-loss drug for her daughter, highlighting gaps in coverage for children with chronic illnesses. Read the family's struggle.
Semaglutide, sold as Ozempic, is now off-patent in Canada. This move could slash costs by up to 75%, dramatically increasing access to the popular diabetes and weight-loss drug for Canadians.
Novo Nordisk's CEO says its new obesity pill will tap into millions not using GLP-1s due to needle fears. The drugmaker battles Eli Lilly and compounders in a massive market.
This high-capacity, 7-compartment pill organizer from Amazon declutters counters and simplifies daily routines. At just $7.99, it's a portable, BPA-free solution praised by reviewers.
Health Canada issues a public warning about counterfeit Viagra and Cialis tablets found at a Mississauga distributor. Learn how to identify fake medications and protect your health.
A Redcliff, Alberta man claims a WestJet flight attendant made inappropriate comments about his weight during a December 2025 flight. The incident is raising questions about airline passenger treatment.
New research shows patients quickly regain weight after ending GLP-1 medications like Wegovy. Experts stress the need for long-term lifestyle strategies. Learn the findings.
Generic versions of weight-loss drug Ozempic could slash costs from $400 to under $100 per month in Quebec following a key patent expiration, potentially increasing access for hundreds of thousands.
Professor Svetlana Mojsov, whose research led to revolutionary drugs like Ozempic, has been awarded the 2026 King Faisal Prize in Medicine. Her work is tackling a global obesity crisis.
Pharmaceutical giant Novo Nordisk is considering a strategic rebrand of a lower-price version of Ozempic to compete directly with upcoming generic alternatives. Learn about the potential market shift.
Novo Nordisk launches Wegovy pill in the U.S., providing a flexible, needle-free option for weight management. Learn about this new alternative to injectable medications.
Dr. Sue Pedersen advises patients to consult their doctors individually about using generic or brand-name Ozempic. A pivotal moment for diabetes and weight-loss treatment access in Canada.
Couples in mixed-weight relationships reveal the intrusive and hurtful comments they receive, challenging societal stigma and affirming that love transcends size. Read their powerful stories.
In a lengthy Wall Street Journal interview, former U.S. President Donald Trump disclosed he takes a daily aspirin dose exceeding medical advice. Read the health details.
Explore how GLP-1 drugs like Ozempic are transforming workplace dynamics, from employer-sponsored benefits to shifting social etiquette. Discover the data behind this growing trend.
A woman seeks advice after a friend makes hurtful remarks about her weight loss and grief. Jeanne Phillips offers two clear strategies for dealing with tactless comments. Read the full dilemma and solution.
Explore how social media trends and digital health apps are transforming access to GLP-1 medications in Canada, moving beyond traditional healthcare channels.
Shares of Novo Nordisk surged nearly 8% after the U.S. FDA approved its Wegovy weight-loss pill. The landmark decision marks a major expansion for the obesity drug market.
U.S. regulators have greenlit a pill version of a leading weight-loss medication, potentially broadening treatment options. Learn about the approval and its implications.
U.S. regulators have approved the Wegovy pill for weight loss, a major development in pharmaceutical treatment. Learn about the details and potential impact of this new drug.
Education strategist Dwayne Matthews shares simple, engaging strategies to help Canadian students retain knowledge over the winter break, turning everyday activities into learning opportunities.
New data shows Eli Lilly's oral weight-loss drug successfully maintains weight reduction after patients switch from injectable medications. A breakthrough for chronic obesity management.
Canadians with chronic pain describe the daily struggle of navigating nationwide shortages of essential pain control medications. Learn about the personal impact and ongoing supply issues.
Learn how to effectively use tax loss harvesting to offset capital gains. Avoid the superficial loss rule and stay invested with our expert guide for Canadian investors.
Weight Watchers launches a fully integrated digital platform offering comprehensive support for members using GLP-1 medications, featuring personalized nutrition, coaching, and community. Discover the future of weight management.
After losing their toddler Aiden, Emily Henderson's family receives a unique gift—an Easy Button with his laugh. A story of grief, memory, and finding joy in the hardest moments. Read their journey.
Health Canada has seized counterfeit erectile dysfunction medications from a Toronto convenience store. Learn the risks and how to protect yourself from dangerous fake drugs.
New Canadian guidelines urge doctors to prescribe HIV prevention drugs without gatekeeping. New data shows a slight decline in diagnoses, but rates remain high in the Prairies.
New Canadian HIV prevention guidelines call for an end to 'gatekeeping' PrEP, urging doctors to offer the preventive medication more readily. Learn about the shift in public health strategy.
Experts warn injectable weight-loss drugs such as Ozempic are reducing consumer appetites, posing a significant challenge to the fast-food sector's traditional business model in Canada.